Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
7.08
+0.10 (1.43%)
At close: Dec 10, 2025, 4:00 PM EST
6.98
-0.10 (-1.41%)
After-hours: Dec 10, 2025, 6:33 PM EST
Evolus Market Cap
Evolus has a market cap or net worth of $458.92 million as of December 10, 2025. Its market cap has decreased by -44.42% in one year.
Market Cap
458.92M
Enterprise Value
581.64M
1-Year Change
-44.42%
Ranking
Category
Stock Price
$7.08
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.32M to $458.92M, an increase of 69.15%. That is a compound annual growth rate of 6.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 452.44M | -35.28% |
| Dec 31, 2024 | 699.07M | 14.94% |
| Dec 29, 2023 | 608.22M | 43.99% |
| Dec 30, 2022 | 422.41M | 16.75% |
| Dec 31, 2021 | 361.81M | 219.06% |
| Dec 31, 2020 | 113.40M | -72.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 893.23B |
| Johnson & Johnson | 485.76B |
| AbbVie | 394.34B |
| UnitedHealth Group | 293.15B |
| AstraZeneca | 280.30B |
| Novartis AG | 253.21B |
| Merck & Co. | 245.55B |
| Thermo Fisher Scientific | 213.48B |